Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 1/20 | 0.49 |
| ▸ | STAT1 | P42224 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.38 |
| ▸ | RELA | Q04206 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 5/20 | 0.36 |
| ▸ | PDE4B | Q07343 | 4/20 | 0.36 |
| ▸ | PDE4A | P27815 | 3/20 | 0.36 |
| ▸ | PDE4C | Q08493 | 3/20 | 0.36 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31384905 | 0.99 | STAT3 (0.48) | STAT3STAT1TP53KDM4ETSHR | |
| SCHEMBL10423762 | 0.99 | STAT3 (0.48) | STAT3STAT1TP53KDM4ETSHR | |
| SCHEMBL28250385 | 0.99 | STAT3 (0.48) | STAT3STAT1TP53KDM4ETSHR | |
| SCHEMBL28337483 | 0.99 | STAT3 (0.48) | STAT3STAT1TP53KDM4ETSHR | |
| SCHEMBL31384871 | 0.99 | STAT3 (0.48) | STAT3STAT1TP53KDM4ETSHR | |
| SCHEMBL28275582 | 0.86 | STAT3 (0.46) | STAT3STAT1TP53KDM4ETSHR | |
| SCHEMBL226837 | 0.85 | STAT3 (0.59) | STAT3STAT1TP53KDM4ETSHR | |
| SCHEMBL6265476 | 0.84 | STAT3 (0.57) | STAT3STAT1TP53KDM4ETSHR | |
| SCHEMBL14054511 | 0.84 | STAT3 (0.57) | STAT3STAT1TP53KDM4ETSHR | |
| SCHEMBL31499126 | 0.82 | STAT3 (0.52) | STAT3STAT1TP53KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5292409-A | Electrolytically generating superoxide ion under protective layer of ion exchange material | CAPE COD RESEARCH, INC. (US) | 1994-03-08 | — | — | US | claimed |
| WO-2025089409-A1 | PHOTOELECTRIC CONVERSION ELEMENT, PHOTOELECTRIC CONVERSION DEVICE, MOBILE BODY, AND BUILDING MATERIAL | キヤノン株式会社 | 2025-05-01 | — | — | WO | disclosed |
| WO-2025089384-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND PHOTOELECTRIC CONVERSION DEVICE | キヤノン株式会社 | 2025-05-01 | — | — | WO | disclosed |
| WO-2025089411-A1 | COMPOSITION, PREPARATION METHOD FOR COMPOSITION, AND PHOTOELECTRIC CONVERSION ELEMENT | キヤノン株式会社 | 2025-05-01 | — | — | WO | disclosed |
| CN-119530876-A | Composite catalyst, electrode carrying composite catalyst, and preparation method and application of electrode | 中国石油化工股份有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-109301266-A | Oxygen reduction catalyst and its preparation method and application | 德州新动能铁塔发电有限公司 | 2019-02-01 | — | — | CN | disclosed |
| CN-107195935-A | CIHT dynamical systems | 辉光能源公司 | 2017-09-22 | — | — | CN | disclosed |
| EP-2586091-A1 | ELECTRODES AND PRODUCTION AND USE THEREOF | BASF SE (DE) | 2013-05-01 | — | — | EP | disclosed |
| WO-2011161598-A1 | ELECTRODES AND PRODUCTION AND USE THEREOF | BASF SE (DE) | 2011-12-29 | — | — | WO | disclosed |
| US-20110136774-A1 | Anti-Apoptotic Benzodiazepine Receptor Ligand Inhibitors | MALFROY-CAMINE BERNARD | 2011-06-09 | — | — | US | disclosed |
| US-20100120738-A1 | ANTI-APOPTOTIC BENZODIAZEPINE RECEPTOR LIGAND INHIBITORS | MALFROY-CAMINE BERNARD | 2010-05-13 | — | — | US | disclosed |
| US-20100087534-A1 | Use of a Photosensitizing Agent in the Treatment or Prevention of an Inflammation-Associated Disorder in the Gastrointestinal Tract of a Mammal | UNIVERSITE DE LAUSANNE (CH) | 2010-04-08 | — | — | US | disclosed |
| EP-1926497-A2 | USE OF A PHOTOSENSITIZING AGENT IN THE TREATMENT OR PREVENTION OF AN INFLAMMATION-ASSOCIATED DISORDER IN THE GASTROINTESTINAL TRACT OF A MAMMAL | Université de Lausanne (CH) | 2008-06-04 | — | — | EP | disclosed |
| WO-2008033444-A2 | ANTI-APOPTOTIC BENZODIAZEPINE RECEPTOR LIGAND INHIBITORS | EUKARION, INC. (US) | 2008-03-20 | — | — | WO | disclosed |
| EP-1856751-A2 | PRODUCTION OF A PLATINUM-FREE CHELATE CATALYST MATERIAL AS AN INTERMEDIATE PRODUCT, AND FURTHER PROCESSING THEREOF TO OBTAIN AN ELECTROCATALYTIC COATING AS A FINAL PRODUCT | Hahn-Meitner-Institut Berlin GmbH (DE) | 2007-11-21 | — | — | EP | disclosed |
| WO-2007004045-A9 | USE OF A PHOTOSENSITIZING AGENT IN THE TREATMENT OR PREVENTION OF AN INFLAMMATION-ASSOCIATED DISORDER IN THE GASTROINTESTINAL TRACT OF A MAMMAL | UNIV LAUSANNE (CH) | 2007-05-31 | — | — | WO | disclosed |
| WO-2007004045-A2 | USE OF A PHOTOSENSITIZING AGENT IN THE TREATMENT OR PREVENTION OF AN INFLAMMATION-ASSOCIATED DISORDER IN THE GASTROINTESTINAL TRACT OF A MAMMAL | UNIVERSITE DE LAUSANNE (CH) | 2007-01-11 | — | — | WO | disclosed |
| CN-1279907-C | Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy | BROOKHAVEN SCIENCE ASS LLC (US) | 2006-10-18 | — | — | CN | disclosed |
| WO-2006086979-A2 | PRODUCTION OF A PLATINUM-FREE CHELATE CATALYST MATERIAL AS AN INTERMEDIATE PRODUCT, AND FURTHER PROCESSING THEREOF TO OBTAIN AN ELECTROCATALYTIC COATING AS A FINAL PRODUCT | HAHN-MEITNER-INSTITUT BERLIN GMBH (DE) | 2006-08-24 | — | — | WO | disclosed |
| CN-1620289-A | Novel metalloporphyrin compounds and their use as radiosensitizers in radiotherapy | BROOKHAVEN SCIENCE ASS LLC (US) | 2005-05-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100120738-A1 | ANTI-APOPTOTIC BENZODIAZEPINE RECEPTOR LIGAND INHIBITORS | AIFM1, BAK1, BAX | STAT3 2102/4885STAT1 3428/4885TP53 2149/4885 |
| US-20110136774-A1 | Anti-Apoptotic Benzodiazepine Receptor Ligand Inhibitors | AIFM1, BAK1, BAX | STAT3 2102/4885STAT1 3428/4885TP53 2149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.